[Impact of highly active antiretroviral therapy on plasma MCP-1 and MSP in AIDS patients]

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Mar;36(2):174-8. doi: 10.3785/j.issn.1008-9292.2007.02.013.
[Article in Chinese]

Abstract

Objective: To study the effect of highly active antiretroviral therapy (HAART) on plasma levels of MSP and MCP-1 in AIDS patients.

Methods: Forty Chinese AIDS patients were treated with HAART for 3 months and 84 German AIDS patients with HAART for 3 to 6 years. The pre-treatment and post-treatment plasma levels of MSP and MCP-1 were measured by enzyme-linked immunosorbent assay (ELISA), and their correlations with CD4+ cell counts and viral loads were analyzed.

Result: The mean levels of MCP-1 were significantly higher and MSP were significantly lower in HIV-infected patients compared with the HIV-negative controls (P <0.01). After HAART for three months, there were no significant changes in the levels of these cytokines. But after long-term HAART (for 3 to 6 y), the level of MCP-1 was increased and that of MSP decreased significantly (P<0.01). There was a negative correlation between MSP and MCP-1 levels, and the same for MSP level and CD4+ cell counts; while there was a positive correlation between MCP-1 levels and CD4+ cell counts.

Conclusion: The changed plasma levels of MSP and MCP-1 are associated with HIV-1 infection and HAART may reverse the levels of these two cytokines.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / blood*
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Chemokine CCL2 / blood*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Macrophage-Activating Factors / blood*
  • Male
  • Middle Aged
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Chemokine CCL2
  • Macrophage-Activating Factors